Close

Quidel Corp (QDEL) Cleared by FDA to Market Lyra Direct Strep Assay

April 22, 2014 2:31 PM EDT Send to a Friend
Quidel Corporation (Nasdaq: QDEL) announced that it has received clearance, via the De Novo Request process, from the United States ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login